Special presentations of thyroid cancer in pregnancy, renal failure, thyrotoxicosis, and struma ovarii

Thyroid Cancer (Second Edition): A Comprehensive Guide to Clinical Management

Volumn , Issue , 2006, Pages 387-392

  Burman, Kenneth D ^a,b,c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547381365     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-995-0_44     Document Type: Chapter

References (43)

1. Stocker DJ, Burch HB. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol 2003; 28:205-212.
2. Filetti S, Belfiore A, Amir SM, et al. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 1988; 318:753-759.
3. Basaria S, Salvatori R. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease. J Endocrinol Invest 2002; 25:639-642.
4. Guglielmi R, Pacella CM, Dottorini ME, et al. Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablation. Thyroid 1999; 9: 173-177.
5. Alagol F, Tanakol R, Boztepe H, et al. Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review. Thyroid 1999; 9:1029-1032.
6. Salvatori M, Saletnich I, Rufini V, et al. Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer. J Nucl Med 1998; 39:1202-1207.
7. Holst J, Jonklaas J, Atkins F, et al. Dosimetric analysis of radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end stage renal disease on hemodialysis; Thyroid, in press.
8. Jimenez RG, Moreno AS, Gonzalez EN, et al. Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing d ialysis for chronic renal failure: a dosimetric method. Thyroid 2001; 11:1031-1034.
9. Mello A, Isaacs R, Petersen J, et al. Management of papillary thyroid carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis. Clin Nuc Med 1992; 19:776-781.
10. Alexander EK, Marqusee E, Lawrence J, et al. T iming and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351:241-249.
11. Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid 1999; 9:631-635.
12. Toft A. Increased levothyroxine requirements in pregnancy-why, when, and how much? N Engl J Med 2004; 351:292-294.
13. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000; 151:765-772.
14. Mack WJ, Preston-Martin S, Bernstein L, et al. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999; 8:991-997.
15. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997; 82: 2862-2866.
16. Marley EF, Oertel YC. Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women. D iagn Cytopathol 1997; 16:122-125.
17. Thomas AK, McVie R, Levine SN. Disorders of maternal calcium metabolism implicated by abnormal calcium metabolism in the neonate. Am J Perinatol 1999; 16:515-520.
18. Robertson WC, Jr. Calcium carbonate consumption during pregnancy: an unusual cause of neonatal hypocalcemia. J Child Neurol 2002; 17: 853-855.
19. Chopra IJ, Baber K. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy? Metabolism 2003; 52:122-128.
20. Lin JD, Wang HS, Weng HF, Kao PF. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas. J Endocrinol Invest 1998; 21:662-667.
21. Ayala C, Navarro E, Rodriguez JR, et al. Conception after iodine-131 therapy for differentiated thyroid cancer. Thyroid 1998; 8:1009-1011.
22. Chow SM, Yau S, Lee SH, et al. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys 2004; 59: 992-1000.
23. Vini L, Hyer S, Al-Saadi A, et al. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002; 78:92-93.
24. Takeuchi K, Murata K, Fujita I. "Malignant struma ovarii" with peritoneal metastasis: report of two cases. Eur J Gynaecol Oncol 2000; 21: 260-261.
25. Chan SW, Farrell KE. Metastatic thyroid carcinoma in the presence of struma ovarii. Med J Aust 2001; 175:373-374.
26. Checrallah A, Medlej R, Saade C, et al. Malignant struma ovarii: an unusual presentation. Thyroid 2001; 11:889-892.
27. Dardik RB, Dardik M, Westra W, Montz FJ. Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol 1999; 73:447-451.
28. Griffiths AN, Jain B, Vine SJ. Papillary thyroid carcinoma of struma ovarii. J Obstet Gynaecol 2004; 24:92-93.
29. Huh JJ, Montz FJ, Bristow RE. Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125. Gynecol Oncol 2002; 86:231-234.
30. Hemli JM, Barakate MS, Appleberg M, Delbridge LW. Papillary carcinoma of the thyroid arising in struma ovari-report of a case and review of management guidelines. Gynecol Endocrinol 2001; 15: 243-247.
31. Logani S, Baloch ZW, Snyder PJ, et al. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report. Thyroid 2001; 11: 1073-1075.
32. Nahn PA, Robinson E, Strassman M. Conservative therapy for malignant struma ovarii. A case report. J Reprod Med 2002; 47: 943-945.
33. Ribeiro-Silva A, Bezerra AM, Serafini LN. Malignant struma ovarii: an autopsy report of a clinically unsuspected tumor. Gynecol Oncol 2002; 87:213-215.
34. Rotman-Pikielny P, Reynolds JC, Barker WC, et al. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. J Clin Endocrinol Metab 2000; 85: 237-244.
35. Soto Moreno A, Venegas EM, Rodriguez JR, et al. Thyroid carcinoma on an ovarian teratoma: a case report and review of the literature. Gynecol Endocrinol 2002; 16:207-211.
36. Utsunomiya D, Shiraishi S, Kawanaka K, et al. Struma ovarii coexisting with mucinous cystadenoma detected by radioactive iodine. Clin Nucl Med 2003; 28:725-727.
37. Volpi E, Ferrero A, Nasi PG, Sismondi P. Malignant struma ovarii: a case report of laparoscopic management. Gynecol Oncol 2003; 90: 191-194.
38. Santin AD, Zhan F, Bellone S, et al. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling. Br J Cancer 2004; 90:1814-1824.
39. Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004; 94:456-462.
40. Ryu DR, Yoo TH, Kim YT, et al. Minimal change disease in a patient with ovarian papillary serous carcinoma. Gynecol Oncol 2004; 93: 554-556.
41. Byrd MC, Thompson LD, Wieneke JA. Intratracheal ectopic thyroid tissue: a case report and literature review. Ear Nose Throat J 2003; 82:514-518.
42. Kao SY, Tu H, Chang RC, et al. Primary ectopic thyroid papillary carcinoma in the floor of the mouth and tongue: a case report. Br J Oral Maxillofac Surg 2002; 40:213-215.
43. LiVolsi VA, Perzin KH, Savetsky L. Carcinoma arising in median ectopic thyroid (including thyroglossal duct tissue). Cancer 1974; 34: 1303-1315.